Contribution: Industrial Research Assistance Program – Contributions to Firms
ImmunoFlex Therapeutics Inc.
$36,420.00
Development and optimization of bioinformatics-based evaluation technologies for the measurement of changes in immune repertoire
FY 2020-21 · 2021-01-04
Summary
The project involves developing computational methods to measure changes in the repertoire of lymphocyte receptors critical for adaptive immunity. These methods will help measure the impact of Immunoflex products.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
West Vancouver|West Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
733478275
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-01-04 | 2020-21 | $36,420.00 |
| 1 | 2021-01-04 | 2020-21 | $36,420.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 153 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 153 jours.
Agreement End Date
2021-11-30
Agreement Number
963057
Agreement Start Date
2021-01-04
Agreement Title
Development and optimization of bioinformatics-based evaluation technologies for the measurement of changes in immune repertoire
Agreement Title (French)
Développement et optimisation de technologies d'évaluation basées sur la bioinformatique pour la mesure des changements dans le répertoire immunitaire
Agreement Type
Contribution
Agreement Value
$36,420.00
Amendment Date
2021-06-24
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project involves developing computational methods to measure changes in the repertoire of lymphocyte receptors critical for adaptive immunity. These methods will help measure the impact of Immunoflex products.
Description (French)
Le projet consiste à concevoir des méthodes de calcul pour mesurer les changements dans le répertoire des récepteurs lymphocytaires essentiels à l'immunité adaptative. Ces méthodes permettront de mesurer l'impact des produits Immunoflex.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
West Vancouver--Sunshine Coast--Sea to Sky Country
Federal Riding (French)
West Vancouver--Sunshine Coast--Sea to Sky Country
Federal Riding Number
59042
NAICS Code
3254
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
733478275
Recipient City
West Vancouver|West Vancouver
Recipient Country
CA
Recipient Legal Name
ImmunoFlex Therapeutics Inc.
Recipient Postal Code
V7W 1K3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2020-2021-Q4-963057
